Idelalisib Given Front-Line for Treatment of Chronic Lymphocytic Leukemia Causes Frequent Immune-Mediated Hepatotoxicity
AuthID
P-00M-3FR
P-00M-3FR
© 2025 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service